| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/13/2003 | US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections |
| 03/13/2003 | US20030049699 Polypeptide for use in the treatment of cell proliferation disorders |
| 03/13/2003 | US20030049697 Detection of potassium channel modulators for treatment of heart, vascular and endrocrine pathologies; obtain sample, incubate with modulator, monitor effect of modulator on transport protein activity |
| 03/13/2003 | US20030049694 Production of fusion proteins and use for identifying binding molecules |
| 03/13/2003 | US20030049691 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander |
| 03/13/2003 | US20030049690 Detection of DNA damaging agents |
| 03/13/2003 | US20030049689 Generation of polypeptide for use in the treatment of injuries, infections and cancer; obtain library of peptides, join to generate polypeptide, evaluate activity of polypeptide |
| 03/13/2003 | US20030049688 Protein fragment complementation assays for the detection of biological or drug interactions |
| 03/13/2003 | US20030049686 Generation of mutant protein library; obtain nucleotide sequences coding mutant proteins, incubate with cells, transform cells, recover transformed cells, propagate, recover cloned sequences coding mutant protein |
| 03/13/2003 | US20030049683 Rationally designed antibodies |
| 03/13/2003 | US20030049682 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2003 | US20030049681 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049675 Extraction of nucleotide sequences from microorganisms; obtain microorganism, grind sample, embed in agarose, extract nucleotide sequences, expose to electrophoresis, extract nucleotide sequences |
| 03/13/2003 | US20030049674 Nucleotide sequences coding peptide for use in the treatment of autoimmune diseases |
| 03/13/2003 | US20030049671 Surface-modified supporting materials for binding biological materials, methods for the production and use thereof |
| 03/13/2003 | US20030049669 Protein for use in detection of bacterial infections |
| 03/13/2003 | US20030049668 Method for determining quinolon resistance of tubercle bacilli |
| 03/13/2003 | US20030049665 Method for converting single-copy BAC vectors to conditional high-copy pBAC/oriHC vectors |
| 03/13/2003 | US20030049662 Oligonucleotides for use in the treatment of wounds, cardiovascular, cell proliferative and developmental disorders |
| 03/13/2003 | US20030049661 Proteins for use in the treatment and diagnosis of brain and nervous system disorders |
| 03/13/2003 | US20030049656 High throughput screening assay for detecting a DNA sequence |
| 03/13/2003 | US20030049655 Nucleotide sequence amplification; obtain nucleotide sequences, incubate with reaction mixture, digest with pyrophosphatase, amplify nucleotide sequences |
| 03/13/2003 | US20030049654 Protein design automation for protein libraries |
| 03/13/2003 | US20030049653 Method for serial analysis of gene expression |
| 03/13/2003 | US20030049651 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer |
| 03/13/2003 | US20030049649 Targeted modification of chromatin structure |
| 03/13/2003 | US20030049648 37 staphylococcus aureus genes and polypeptides |
| 03/13/2003 | US20030049647 Generation of binding profile of test compound; obtain fusion protein, incubate with modulator, expose to binding agent, monitor binding pattern |
| 03/13/2003 | US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders |
| 03/13/2003 | US20030049638 Nucleotide sequences coding polypeptide for use in the treatment and prevention of cell proliferative, nervous system and tumor disorders |
| 03/13/2003 | US20030049637 Process for preparation full-length cDNA and anchor used for the same |
| 03/13/2003 | US20030049632 Electronically mediated nucleic acid amplification in NASBA |
| 03/13/2003 | US20030049628 Detection of preferential mutations in nucleotide sequences; obtain nucleotide sequences, incubate with primer, expose to labeled reaction mixture, detect amplification products, presence of product indicate nucleotiede sequences mutation |
| 03/13/2003 | US20030049625 Rapid and sensitive proximity-based assay for the detection and quantification of DNA binding proteins |
| 03/13/2003 | US20030049619 Generation of preferential oligonucleotides obtain nucleotide sequences, incubate with primers and polymerase, propagate and recover sequences |
| 03/13/2003 | US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 03/13/2003 | US20030049616 Enzymatic synthesis of oligonucleotide tags |
| 03/13/2003 | US20030049615 Primer for use in nucleotide sequences amplification for detecting and classifying polymorphisms |
| 03/13/2003 | US20030049614 Nucleotide sequences coding polymerase for use in amplifying, synthesizing and mutagenizing nucleic acids |
| 03/13/2003 | US20030049609 Viral proteins capable of binding LAR |
| 03/13/2003 | US20030049607 Protein complex for use in controlling viral propagation in cells |
| 03/13/2003 | US20030049606 Novel anti-viral and anti-proliferative agents derived from STAT1 transcription factor |
| 03/13/2003 | US20030049605 Display of viral proteins |
| 03/13/2003 | US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases |
| 03/13/2003 | US20030049603 Designing preferential chemokines; obtain phage display library, incubate with cells, harvest cells, release phage, incubate with bacteria and clone phage, recover clones |
| 03/13/2003 | US20030049601 Detecting hepatitis in sample; obtain sample, incubate with binding agent, detect complex, presence of complex indicate hepatitis virus |
| 03/13/2003 | US20030049339 Nucleic acid encoding a lectin derived progenitor cell preservation factor |
| 03/13/2003 | US20030049278 Transmission blocking vaccine against malaria |
| 03/13/2003 | US20030049274 PRRSV vaccines |
| 03/13/2003 | US20030049271 Diagnosis, therapy of bacteria infections |
| 03/13/2003 | US20030049270 Hybrid nucleotide sequence |
| 03/13/2003 | US20030049266 Induce immunology response usin gpolynucleotide |
| 03/13/2003 | US20030049265 Heliobacter pylori antigen |
| 03/13/2003 | US20030049264 Releasing neurotransmitters; analgesics |
| 03/13/2003 | US20030049261 Administering chitinase inhibitor |
| 03/13/2003 | US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 03/13/2003 | US20030049255 Interleukin-1 receptors in the treatment of diseases |
| 03/13/2003 | US20030049248 Netrins |
| 03/13/2003 | US20030049243 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 03/13/2003 | US20030049237 Isolated nucleic acids; prevent binding of antigens; peanut allergies |
| 03/13/2003 | US20030049236 Therapy for bone disorders; transduction, cell differentiation |
| 03/13/2003 | US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
| 03/13/2003 | US20030049228 Expression of foreign genes from plant virus vectors |
| 03/13/2003 | US20030049227 Antitumor, anticarcinogenic agents; using fusion protein |
| 03/13/2003 | US20030049203 Targeted nucleic acid constructs and uses related thereto |
| 03/13/2003 | US20030048934 Method for identifying polymorphic markers in a population |
| 03/13/2003 | US20030048452 Imaging spr apparatus |
| 03/13/2003 | US20030048450 In-situ detection and analysis of methane in coal bed methane formations with spectrometers |
| 03/13/2003 | DE3890874C2 Rekombinante Viren Recombinant viruses |
| 03/13/2003 | DE19933024C2 Kationische Blockcopolymere Cationic block copolymers |
| 03/13/2003 | DE10135039C1 Verfahren zur Isolierung großer Varianzen spezifischer Moleküle für ein Zielmolekül aus Phagemid-Gen-Bibliotheken A process for the isolation of large variances of specific molecules for a target molecule from phagemid gene libraries |
| 03/13/2003 | CA2736621A1 Amplification and detection reagents for hiv-1 |
| 03/13/2003 | CA2477811A1 Chicken anemia virus vaccine from cell line |
| 03/13/2003 | CA2460617A1 Method of modifying genome in higher plant |
| 03/13/2003 | CA2459961A1 Protein phosphatase stress-related polypeptides and methods of use in plants |
| 03/13/2003 | CA2459957A1 Culture system for rapid expansion of human embryonic stem cells |
| 03/13/2003 | CA2459816A1 Hybrid and tandem expression of neisserial proteins |
| 03/13/2003 | CA2459796A1 Homing peptides |
| 03/13/2003 | CA2459777A1 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof |
| 03/13/2003 | CA2459728A1 Late gestation lung genes, fragments and uses thereof |
| 03/13/2003 | CA2459725A1 Method of isolating cells and uses thereof |
| 03/13/2003 | CA2459285A1 Method for identifying polymorphic markers in a population |
| 03/13/2003 | CA2459272A1 Novel serine protease inhibitory protein mt0039 |
| 03/13/2003 | CA2459269A1 Stable episomal vectors |
| 03/13/2003 | CA2459161A1 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 03/13/2003 | CA2459138A1 Modified human growth hormone |
| 03/13/2003 | CA2459136A1 A caspase-8 binding protein, its preparation and use |
| 03/13/2003 | CA2459079A1 Plant-derived resistance gene |
| 03/13/2003 | CA2459077A1 Diagnosis of carcinomas |
| 03/13/2003 | CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 03/13/2003 | CA2458985A1 Antibodies against caspase-8, their preparation and use |
| 03/13/2003 | CA2458953A1 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation |
| 03/13/2003 | CA2458926A1 Methods of treating infection by drug resistant bacteria |
| 03/13/2003 | CA2458915A1 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 03/13/2003 | CA2458879A1 Genetic construct intracellular monitoring system |
| 03/13/2003 | CA2458786A1 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof |
| 03/13/2003 | CA2458780A1 Targeted nucleic acid constructs and uses related thereto |
| 03/13/2003 | CA2458777A1 Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| 03/13/2003 | CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 03/13/2003 | CA2458664A1 Nucleic acid archiving |